wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q51359715-F485BCD5-84AD-4400-8B80-25131F4584BE
Q51359715-F485BCD5-84AD-4400-8B80-25131F4584BE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q51359715-F485BCD5-84AD-4400-8B80-25131F4584BE
The EGALITY study: a confirmatory, randomized, double-blind study comparing the efficacy, safety and immunogenicity of GP2015, a proposed etanercept biosimilar, vs. the originator product in patients with moderate-to-severe chronic plaque-type psori
P2860
Q51359715-F485BCD5-84AD-4400-8B80-25131F4584BE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q51359715-F485BCD5-84AD-4400-8B80-25131F4584BE
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
5189572f23cc97dddcf5b45e8f1082c81f378288
P2860
A randomised, double-blind, phase III study comparing SB2, an infliximab biosimilar, to the infliximab reference product Remicade in patients with moderate to severe rheumatoid arthritis despite methotrexate therapy.